Prognostic value of integrated dynamic NLR and [18F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.